A subtype of multiple sclerosis defined by an activated immune defense program

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Genes and Immunity

• Publication date

  2006-07-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.gene.6364324PMID 16837931
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients

  2007cited by this paper
• Gene expression profiling in rheumatology.

  2007cited by this paper
• Multiple Sclerosis

  2007cited by this paper
• Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism.

  2005cited by this paper
• MRI as a marker for disease heterogeneity in multiple sclerosis

  2005cited by this paper
• Interferon‐α/β–mediated innate immune mechanisms in dermatomyositis

  2005cited by this paper
• Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis.

  2005cited by this paper
• From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

  2005cited by this paper
• Role of oxidative damage in the pathogenesis of viral infections of the nervous system.

  2005cited by this paper
• TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway.

  2005cited by this paper
• Insights into host responses against pathogens from transcriptional profiling

  2005cited by this paper
• Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis.

  2005cited by this paper
• Blood transcriptional signatures of multiple sclerosis: Unique gene expression of disease activity

  2004cited by this paper
• The PANTHER database of protein families, subfamilies, functions and pathways

  2004cited by this paper
• Autoimmunity gene expression portrait: specific signature that intersects or differentiates between multiple sclerosis and systemic lupus erythematosus

  2004cited by this paper
• The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

  2004cited by this paper
• Toll-like receptor signalling

  2004cited by this paper
• Transcription-Based Prediction of Response to IFNβ Using Supervised Computational Methods

  2004cited by this paper
• The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model.

  2004cited by this paper
• Missorting of LaCrosse Virus Nucleocapsid Protein by the Interferon‐Induced MxA GTPase Involves Smooth ER Membranes

  2004cited by this paper
• The Stanford Microarray Database accommodates additional microarray platforms and data formats

  2004cited by this paper
• Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG.

  2004cited by this paper
• Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene.

  2004cited by this paper
• PANTHER: a library of protein families and subfamilies indexed by function.

  2003cited by this paper
• Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

  2003cited by this paper
• Faculty Opinions recommendation of PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.

  2003cited by this paper
• Genomic Effects of IFN-β in Multiple Sclerosis Patients 1

  2003cited by this paper
• Expression profiling identifies responder and non-responder phenotypes to interferon-beta in multiple sclerosis.

  2003cited by this paper
• PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

  2003cited by this paper
• Genomic effects of IFN-beta in multiple sclerosis patients.

  2003cited by this paper
• Microarray analysis identifies interferon beta-regulated genes in multiple sclerosis.

  2003cited by this paper
• Gene expression profiles in human autoimmune disease.

  2003cited by this paper
• Assessment of different treatment failure criteria in a cohort of relapsing–remitting multiple sclerosis patients treated with interferon β: Implications for clinical trials

  2002cited by this paper
• Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation.

  2002cited by this paper
• The worldwide prevalence of multiple sclerosis.

  2002cited by this paper
• Cutting Edge: Molecular Portrait of Human Autoimmune Disease1

  2002cited by this paper
• Antiviral Actions of Interferons

  2001cited by this paper
• Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

  2001cited by this paper
• Increased levels of antiviral MxA protein in peripheral blood of patients with A chronic disease of unknown etiology *

  2001cited by this paper
• Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies

  2000cited by this paper
• Transcription, genomes, function.

  2000cited by this paper
• Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination

  2000cited by this paper
• Mistaken self, a novel model that links microbial infections with myelin-directed autoimmunity in multiple sclerosis.

  2000cited by this paper
• Distinctive gene expression patterns in human mammary epithelial cells and breast cancers.

  1999cited by this paper
• The 2–5 A system: Modulation of viral and cellular processes through acceleration of RNA degradation

  1998cited by this paper
• Cluster analysis and display of genome-wide expression patterns.

  1998cited by this paper
• Mechanism of interferon action: double-stranded RNA-specific adenosine deaminase from human cells is inducible by alpha and gamma interferons.

  1995cited by this paper
• Interferon Expression in the Pancreases of Patients With Type I Diabetes

  1995cited by this paper
• Control of kinetic properties of AMPA receptor channels by nuclear RNA editing.

  1994cited by this paper
• A population‐based study of multiple sclerosis in twins: Update

  1993cited by this paper
• A population-based study of multiple sclerosis in twins: update.

  1993cited by this paper
• Function of the mouse Mx1 protein is inhibited by overexpression of the PB2 protein of influenza virus.

  1993cited by this paper
• Cranial neuropathy

  1991cited by this paper
• Amplified RNA synthesized from limited quantities of heterogeneous cDNA.

  1990cited by this paper
• Methods in molecular medicine.

  1987cited by this paper

• The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis

  2025cites this paper
• The molecular subtypes of autoimmune diseases

  2024cites this paper
• Unexplored power of CRISPR-Cas9 in neuroscience, a multi-OMICs review.

  2024cites this paper
• Cytokine levels in patients with multiple sclerosis and chronic neuroborreliosis

  2024cites this paper
• Leveraging a Comprehensive Unbiased RNAseq Database Uncovers New Human Monocyte-Derived Macrophage Subtypes Within Commonly Employed In Vitro Polarization Methods

  2024cites this paper
• Does multiple sclerosis have a zoonotic origin? Correlations with lymphocytic choriomeningitis virus infection

  2023cites this paper
• Rs205764 and rs547311 in linc00513 may influence treatment responses in multiple sclerosis patients: A pharmacogenomics Egyptian study

  2023cites this paper
• ADAR Expression and Single Nucleotide Variants in Multiple Sclerosis Patients Affect the Response to Interferon Beta Therapy

  2023cites this paper
• Optimal Selection of IFN-α-Inducible Genes to Determine Type I Interferon Signature Improves the Diagnosis of Systemic Lupus Erythematosus

  2023cites this paper
• The link between circulating follicular helper T cells and autoimmunity

  2022cites this paper
• Differentiating central nervous system demyelinating disorders: The role of clinical, laboratory, imaging characteristics and peripheral blood type I interferon activity

  2022cites this paper
• Trained immunity in viral infections, Alzheimer's disease and multiple sclerosis: A convergence in type I interferon signalling and IFNβ-1a.

  2022cites this paper
• Three Decades of Interferon-β in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection?

  2020cites this paper
• Type I and II Interferon Signatures Can Predict the Response to Anti-TNF Agents in Inflammatory Bowel Disease Patients: Involvement of the Microbiota.

  2020cites this paper
• Analysis of chosen SNVs in GPC5, CD58 and IRF8 genes in multiple sclerosis patients.

  2019cites this paper
• In silico identification of potential inhibitors against human 2’-5’-oligoadenylate synthetase (OAS) proteins

  2019cites this paper
• Discovery of Novel Human Biomarkers using Variable Lymphocyte Receptor Antibodies of the Sea Lamprey

  2019cites this paper
• A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis.

  2019cites this paper
• Association of SHMT1, MAZ, ERG, and L3MBTL3 Gene Polymorphisms with Susceptibility to Multiple Sclerosis

  2018cites this paper
• Multiple sclerosis genetics.

  2018cites this paper
• A tyrosine sulfation–dependent HLA-I modification identifies memory B cells and plasma cells

  2018cites this paper
• Role of cellular metabolism in regulating type I interferon responses: Implications for tumour immunology and treatment.

  2017cites this paper
• Involvement of Interferon Regulatory Factor 5 (IRF5) Gene Polymorphisms and Haplotype in Endometriosis-related Infertility

  2017cites this paper
• Endogenous type I interferons and their regulators in multiple sclerosis

  2017cites this paper
• Extracellular 2′5′‐oligoadenylate synthetase 2 mediates T‐cell receptor CD3‐ζ chain down‐regulation via caspase‐3 activation in oral cancer

  2016cites this paper
• Predictors of Response to Multiple Sclerosis Therapeutics in Individual Patients

  2016cites this paper
• Genomics implicates adaptive and innate immunity in Alzheimer's and Parkinson's diseases

  2016cites this paper
• Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases

  2016cites this paper
• Autoantibody Specificities and Type I Interferon Pathway Activation in Idiopathic Inflammatory Myopathies

  2016cites this paper
• Clinical and molecular characterization of the type I interferon signature in rheumatic diseases

  2016cites this paper
• Interferon-Beta, a Decisive Factor in Angiogenesis and Arteriogenesis

  2015cites this paper
• Peptide motif analysis predicts lymphocytic choriomeningitis virus as trigger for multiple sclerosis.

  2015cites this paper
• Endogenous Interferon-β-Inducible Gene Expression and Interferon-β-Treatment Are Associated with Reduced T Cell Responses to Myelin Basic Protein in Multiple Sclerosis

  2015cites this paper
• Autoantibody Specificities and Type I IFN Pathway Activation in Idiopathic Inflammatory Myopathies

  2014cites this paper
• IRF 5 gene variants and pharmacologi al and clinical outcome of IFN-β therapy in MS

  2014cites this paper
• The effect of types I and III interferons on adrenocortical cells and its possible implications for autoimmune Addison's disease

  2014cites this paper
• Molecular mechanism underlying the impact of vitamin D on disease activity of MS

  2014cites this paper
• A Multiple Sclerosis–Associated Variant of CBLB Links Genetic Risk with Type I IFN Function

  2014cites this paper
• Personalized Healthcare in Autoimmune Diseases

  2014cites this paper
• Genome wide differences of gene expression associated with HLA-DRB1 genotype in multiple sclerosis: a pilot study.

  2013cites this paper
• Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls.

  2013cites this paper
• Comparison of IFN-β inducible gene expression in primary-progressive and relapsing-remitting multiple sclerosis.

  2013cites this paper
• Gene expression analysis of relapsing–remitting, primary progressive and secondary progressive multiple sclerosis

  2013cites this paper
• Thiopurine treatment in patients with Crohn's disease leads to a selective reduction of an effector cytotoxic gene expression signature revealed by whole-genome expression profiling.

  2013cites this paper
• Relevance of the type I interferon signature in multiple sclerosis towards a personalized medicine approach for interferon-beta therapy.

  2013cites this paper
• Búsqueda de Biomarcadores Asociados con la Respuesta al Tratamiento con Interferón-beta en Pacientes con Esclerosis Múltiple Remitente-Recurrente

  2013cites this paper
• Endogenous and Recombinant Type I Interferons and Disease Activity in Multiple Sclerosis

  2012cites this paper
• Sarcoidosis triggered by interferon-Beta treatment of multiple sclerosis: a case report and focused literature review.

  2012cites this paper
• Gene Expression Profiling in Rheumatoid Arthritis

  2012cites this paper
• Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance

  2012cites this paper
• Research highlights: Clinical relevance of the type I interferon signature in multiple sclerosis.

  2012cites this paper
• Systems Biology Approaches Reveal a Specific Interferon-Inducible Signature in HTLV-1 Associated Myelopathy

  2012cites this paper
• Interferon signatures in immune disorders and disease

  2012cites this paper
• 3 Gene Expression Profiling in Rheumatoid Arthritis

  2012cites this paper
• Transcriptomics: mRNA and alternative splicing.

  2012cites this paper
• Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis

  2011cites this paper
• Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferon b therapy in multiple sclerosis

  2011cites this paper
• Interferons in Autoimmune and Inflammatory Diseases: Regulation and Roles

  2011cites this paper
• Importance of Correlation between Gene Expression Levels: Application to the Type I Interferon Signature in Rheumatoid Arthritis

  2011cites this paper
• Disease protection and interleukin‐10 induction by endogenous interferon‐β in multiple sclerosis?

  2011cites this paper
• Genetics of multiple sclerosis.

  2011cites this paper
• Differences in exon expression and alternatively spliced genes in blood of multiple sclerosis compared to healthy control subjects.

  2011cites this paper
• Excessive Biologic Response to IFNβ Is Associated with Poor Treatment Response in Patients with Multiple Sclerosis

  2011cites this paper
• Function of histone deacetylase inhibitors in inflammation.

  2011cites this paper
• Genetic Epidemiological Studies of Multiple Sclerose

  2011cites this paper
• Type I IFN and TNFα cross-regulation in immune-mediated inflammatory disease: basic concepts and clinical relevance

  2010cites this paper
• Pharmacogenomics of infliximab treatment using peripheral blood cells of patients with rheumatoid arthritis

  2010cites this paper
• Measuring disease progression in MS: do patients' and physicians' perspectives match?

  2010cites this paper
• Multiple sclerosis etiology: beyond genes and environment

  2010cites this paper
• Different Strains of Theiler's Murine Encephalomyelitis Virus Antagonize Different Sites in the Type I Interferon Pathway

  2010cites this paper
• Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment

  2010cites this paper
• Smad 7 in T cells drives T helper 1 responses in multiple sclerosis and experimental autoimmune encephalomyelitis

  2010cites this paper
• Overview of the biology of type I interferons

  2010cites this paper
• Type I interferon in organ-targeted autoimmune and inflammatory diseases

  2010cites this paper
• Gene expression profiling in autoantibody-positive patients with arthralgia predicts development of arthritis.

  2010cites this paper
• Specific gene expression signature associated with development of autoimmune type-I diabetes using whole-blood microarray analysis

  2010cites this paper
• Nuevos factores genéticos en la esclerosis múltiple: mutación R92Q en el gen TNFRSF1A y el síndrome autoinflamatorio TRAPS

  2010cites this paper
• Smad7 in T cells drives T helper 1 responses in multiple sclerosis and experimental autoimmune encephalomyelitis

  2010cites this paper
• Heterogenomics of autoimmunity towards personalized medicine

  2009influential citation
• Molecular subtypes of systemic sclerosis in association with anti-centromere antibodies and digital ulcers

  2009cites this paper
• Whole genome analysis of the action of interferon-beta.

  2009cites this paper
• Genetic analysis of chromosomal regions 2q33, 7q32 and 19q13 in multiple sclerosis susceptibility

  2009cites this paper
• Genetic Variation and Expression of the IRF5 Gene in Autoimmune Diseases

  2009cites this paper
• A Common Pathway for All Autoimmune Diseases? The Unholy Alliance of Environment, Cell Death and Nucleic Acids

  2009cites this paper
• Pharmacogenomics of IFN-beta in multiple sclerosis: towards a personalized medicine approach.

  2009cites this paper
• Identifying patient subtypes in multiple sclerosis and tailoring immunotherapy : challenges for the future

  2009cites this paper
• Whole genome analysis of the action of interferon -

  2009cites this paper
• Constrained mixture estimation for analysis and robust classification of clinical time series

  2009cites this paper
• Review: Identifying patient subtypes in multiple sclerosis and tailoring immunotherapy: challenges for the future

  2009cites this paper
• Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci

  2009cites this paper
• A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis.

  2009cites this paper
• Association of IRF5 gene polymorphisms with rheumatoid arthritis in a Tunisian population

  2008cites this paper
• Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations

  2008cites this paper
• Genomic studies in ageing research: the need to integrate genetic and gene expression approaches

  2008cites this paper
• Pharmacogenomics of Interferon-ß Therapy in Multiple Sclerosis: Baseline IFN Signature Determines Pharmacological Differences between Patients

  2008influential citation
• Genes implicated in multiple sclerosis pathogenesis from consilience of genotyping and expression profiles in relapse and remission

  2008cites this paper
• CARACTERIZACIÓN DE LA EXPRESIÓN GÉNICA INDUCIDA POR INTERFERÓN BETA EN LEUCOCITOS

  2007cites this paper
• Xaf-1, marqueur diagnostique de sensibilite a l'interferon dans le traitement de la sclerose en plaques

  2007cites this paper
• The complex etiology of multiple sclerosis.

  2007cites this paper
• Defining a new molecular basis of systemic lupus erythematosus through transcriptional profiling

  2007cites this paper